JP Morgan Chase
AMAM

JP Morgan Chase’s Ambrx Biopharma Inc AMAM Stock Holding History

JP Morgan Chase’s Portfolio AMAM Stock Details AMAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,312
Closed -$175K – 8049
2023
Q4 		$175K Buy
+12,312
New +$140K ﹤0.01% 5464
2023
Q3 		– Sell
-157,858
Closed -$2.6M – 7804
2023
Q2 		$2.6M Buy
+157,858
New +$1.98M ﹤0.01% 3342

JP Morgan Chase's AMAM Position: Q1 2024 in Review

JP Morgan Chase sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 12,312 shares — an estimated $175K sold.

JP Morgan Chase first reported a position in AMAM in Q2 2023 and held it in 2 quarters. The position peaked at $2.6M in Q2 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

  • JP Morgan Chase reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
  • JP Morgan Chase sold 12,312 Ambrx Biopharma Inc shares in Q1 2024, an estimated $175K.
  • JP Morgan Chase first reported a position in Ambrx Biopharma Inc in Q2 2023 and held it in 2 quarters.
  • JP Morgan Chase's Ambrx Biopharma Inc position peaked at $2.6M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.